​

Molina Healthcare (MOH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MOH Stock Forecast

Molina Healthcare stock forecast is as follows: an average price target of $347.00 (represents a 17.73% upside from MOH’s last price of $294.73) and a rating consensus of 'Hold', based on 8 wall street analysts offering a 1-year stock forecast.

MOH Price Target

The average price target for Molina Healthcare (MOH) is $347.00 based on 1-year price targets from 8 Wall Street analysts in the past 3 months, with a price target range of $400.00 to $297.00. This represents a potential 17.73% upside from MOH's last price of $294.73.

MOH Analyst Ratings

Hold

According to 8 Wall Street analysts, Molina Healthcare's rating consensus is 'Hold'. The analyst rating breakdown for MOH stock is 0 'Strong Buy' (0.00%), 3 'Buy' (37.50%), 5 'Hold' (62.50%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Molina Healthcare Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 24, 2024Michael HaRobert W. Baird$331.00$275.0020.36%12.31%
Aug 05, 2024Stephen BaxterWells Fargo$360.00$346.973.76%22.15%
Jul 24, 2024David WindleyJefferies$297.00$286.903.52%0.77%
Jul 15, 2024David MacDonaldTruist Financial$400.00$292.8436.59%35.72%
May 29, 2024Michael HaRobert W. Baird$405.00$315.0028.57%37.41%
Apr 25, 2024Andrew MokBarclays$430.00$367.4117.04%45.90%
Apr 15, 2024Stephen BaxterWells Fargo$410.00$376.578.88%39.11%
Feb 15, 2024Stephen BaxterWells Fargo$420.00$398.145.49%42.50%
Jan 04, 2023Barclays$375.00$318.9217.58%27.24%
Jan 03, 2023Wells Fargo$340.00$318.926.61%15.36%
Aug 26, 2022Wells Fargo$345.00$327.505.34%17.06%
Jul 29, 2022Mizuho Securities$366.00$318.1915.03%24.18%
Jul 29, 2022Barclays$380.00$319.4718.95%28.93%
May 25, 2022Wells Fargo$301.00$312.59-3.71%2.13%
May 02, 2022Deutsche Bank$311.00$306.071.61%5.52%
Oct 29, 2021Scott FidelStephens$300.00$295.721.45%1.79%
Oct 29, 2021Steven ValiquetteBarclays$340.00$295.7214.97%15.36%
Apr 14, 2021David WindleyJefferies$253.00$244.163.62%-14.16%

The latest Molina Healthcare stock forecast, released on Oct 24, 2024 by Michael Ha from Robert W. Baird, set a price target of $331.00, which represents a 20.36% increase from the stock price at the time of the forecast ($275.00), and a 12.31% increase from MOH last price ($294.73).

Molina Healthcare Price Target by Period

1M3M12M
# Anlaysts-18
Avg Price Target-$331.00$381.63
Last Closing Price$294.73$294.73$294.73
Upside/Downside-100.00%12.31%29.48%

In the current month, the average price target of Molina Healthcare stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Molina Healthcare's last price of $294.73. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Oct 24, 2024StephensEqual-WeightEqual-WeightHold
Oct 24, 2024Wells FargoBuyBuyHold
Oct 01, 2024Wells FargoBuyBuyHold
Sep 10, 2024Wells FargoBuyBuyHold
Aug 05, 2024Wells FargoEqual-WeightEqual-WeightHold
Jul 29, 2024Cowen & Co.BuyBuyHold
Jul 24, 2024JefferiesHoldHoldHold
Jul 15, 2024Wells FargoBuyBuyHold
May 30, 2024Wells FargoBuyBuyHold
Apr 30, 2024Cowen & Co.BuyBuyHold
Apr 25, 2024Wells FargoBuyBuyHold
Apr 25, 2024BarclaysEqual-WeightEqual-WeightHold
Apr 15, 2024Wells FargoEqual-WeightEqual-WeightHold
Mar 28, 2024Bank of America SecuritiesNeutralUnderperformDowngrade
Feb 09, 2024UBSNeutralNeutralHold
Dec 21, 2023UBSEqual-WeightEqual-WeightHold
Apr 28, 2023Wells FargoUnderweightUnderweightHold
Jan 04, 2023BarclaysOverweightOverweightHold
Jan 03, 2023Wells FargoUnderweightUnderweightHold
Dec 13, 2022Bank of America SecuritiesNeutralUpgrade
Aug 26, 2022Wells FargoUnderweightEqual-WeightDowngrade
Aug 26, 2022Wells FargoUnderweightUnderweightHold
Jul 29, 2022BarclaysOverweightOverweightHold
May 02, 2022Deutsche BankHoldHoldHold
Feb 22, 2022Morgan StanleyOverweightOverweightHold

Molina Healthcare's last stock rating was published by Stephens on Oct 24, 2024. The company gave MOH a "Equal-Weight" rating, the same as its previous rate.

Molina Healthcare Financial Forecast

Molina Healthcare Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue--------------$8.33B$8.15B$8.22B$7.93B$8.05B$7.77B$7.41B$7.04B$6.80B$6.52B$5.24B$5.02B$4.62B$4.55B$4.27B$4.20B
Avg Forecast$12.04B$12.01B$11.65B$11.58B$11.32B$11.05B$10.68B$10.52B$10.32B$9.91B$9.75B$9.45B$8.35B$8.24B$8.32B$8.31B$7.87B$7.81B$7.69B$7.52B$7.19B$6.78B$6.40B$6.07B$5.30B$4.85B$4.74B$4.49B$4.28B$4.15B
High Forecast$13.32B$13.29B$12.90B$12.82B$12.53B$12.23B$11.82B$11.47B$11.41B$9.92B$9.75B$9.45B$8.46B$8.45B$9.21B$9.20B$8.71B$7.81B$7.69B$7.52B$7.19B$6.78B$6.40B$6.07B$5.30B$4.85B$4.74B$4.49B$4.28B$4.15B
Low Forecast$11.47B$11.44B$11.10B$11.03B$10.79B$10.52B$10.17B$10.10B$9.93B$9.90B$9.75B$9.45B$8.28B$7.87B$7.93B$7.92B$7.50B$7.81B$7.69B$7.52B$7.19B$6.78B$6.40B$6.07B$5.30B$4.85B$4.74B$4.49B$4.28B$4.15B
# Analysts33454527844451159544755107599955
Surprise %--------------1.00%0.98%1.04%1.01%1.05%1.03%1.03%1.04%1.06%1.07%0.99%1.04%0.97%1.01%1.00%1.01%

Molina Healthcare's average Quarter revenue forecast for Sep 23 based on 11 analysts is $8.24B, with a low forecast of $7.87B, and a high forecast of $8.45B. MOH's average Quarter revenue forecast represents a -1.09% decrease compared to the company's last Quarter revenue of $8.33B (Jun 23).

Molina Healthcare EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts33454527844451159544755107599955
EBITDA--------------$485.00M$499.00M$360.00M$380.00M$405.00M$412.00M$201.00M$253.00M$304.00M$368.00M$105.00M$312.00M$440.00M$294.00M$263.00M$276.00M
Avg Forecast$629.34M$627.92M$609.29M$605.42M$591.86M$577.54M$558.12M$550.15M$539.52M$518.12M$509.52M$472.85M$436.35M$430.57M$435.02M$429.86M$216.40M$419.27M$412.43M$390.78M$385.77M$363.99M$343.49M$292.00M$284.26M$260.14M$254.28M$287.02M$229.75M$222.41M
High Forecast$696.59M$695.02M$674.41M$670.12M$655.11M$639.26M$617.76M$599.60M$596.56M$518.59M$509.52M$567.41M$442.13M$441.81M$481.51M$515.83M$259.67M$419.27M$412.43M$468.94M$385.77M$363.99M$343.49M$350.40M$284.26M$260.14M$254.28M$344.43M$229.75M$222.41M
Low Forecast$599.54M$598.19M$580.45M$576.76M$563.84M$550.19M$531.69M$528.00M$518.97M$517.65M$509.52M$378.28M$432.67M$411.61M$414.43M$343.89M$173.12M$419.27M$412.43M$312.62M$385.77M$363.99M$343.49M$233.60M$284.26M$260.14M$254.28M$229.62M$229.75M$222.41M
Surprise %--------------1.11%1.16%1.66%0.91%0.98%1.05%0.52%0.70%0.89%1.26%0.37%1.20%1.73%1.02%1.14%1.24%

11 analysts predict MOH's average Quarter EBITDA for Sep 23 to be $430.57M, with a high of $441.81M and a low of $411.61M. This is -11.22% lower than Molina Healthcare's previous annual EBITDA (Jun 23) of $485.00M.

Molina Healthcare Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts33454527844451159544755107599955
Net Income--------------$309.00M$321.00M$56.00M$230.00M$248.00M$258.00M$103.00M$143.00M$185.00M$228.00M$34.00M$185.00M$276.00M$178.00M$168.00M$175.00M
Avg Forecast$400.66M$423.35M$460.24M$442.05M$358.92M$372.88M$395.52M$380.85M$332.82M$334.96M$321.02M$296.10M$250.65M$281.59M$294.19M$269.18M$110.89M$245.40M$252.09M$244.71M$159.98M$163.01M$197.21M$180.91M$55.61M$127.86M$285.89M$173.78M$154.33M$158.02M
High Forecast$456.32M$482.16M$524.18M$503.46M$408.78M$424.68M$450.47M$390.66M$339.70M$342.05M$322.65M$355.32M$259.38M$291.98M$335.06M$323.02M$133.07M$245.40M$252.09M$293.65M$159.98M$163.01M$197.21M$217.10M$55.61M$127.86M$285.89M$208.53M$154.33M$158.02M
Low Forecast$376.00M$397.29M$431.91M$414.84M$336.83M$349.93M$371.18M$369.88M$311.06M$327.86M$319.39M$236.88M$246.58M$269.47M$276.09M$215.35M$88.71M$245.40M$252.09M$195.77M$159.98M$163.01M$197.21M$144.73M$55.61M$127.86M$285.89M$139.02M$154.33M$158.02M
Surprise %--------------1.05%1.19%0.51%0.94%0.98%1.05%0.64%0.88%0.94%1.26%0.61%1.45%0.97%1.02%1.09%1.11%

Molina Healthcare's average Quarter net income forecast for Sep 23 is $281.59M, with a range of $269.47M to $291.98M. MOH's average Quarter net income forecast represents a -8.87% decrease compared to the company's last Quarter net income of $309.00M (Jun 23).

Molina Healthcare SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts33454527844451159544755107599955
SG&A--------------$618.00M$591.00M$629.00M$560.00M$551.00M$571.00M$579.00M$532.00M$484.00M$473.00M$450.00M$368.00M$345.00M$317.00M$343.00M$344.00M
Avg Forecast$896.13M$894.11M$867.59M$862.07M$842.76M$822.37M$794.72M$783.37M$768.24M$737.77M$725.52M$655.33M$621.33M$613.09M$619.44M$595.75M$623.35M$581.74M$572.25M$541.59M$535.26M$505.04M$476.59M$375.32M$394.41M$360.95M$352.81M$309.48M$318.78M$308.59M
High Forecast$991.90M$989.66M$960.31M$954.20M$932.83M$910.25M$879.65M$853.79M$849.45M$738.44M$725.52M$786.39M$629.57M$629.11M$685.63M$714.90M$748.02M$581.74M$572.25M$649.91M$535.26M$505.04M$476.59M$450.38M$394.41M$360.95M$352.81M$371.37M$318.78M$308.59M
Low Forecast$853.71M$851.78M$826.52M$821.26M$802.87M$783.44M$757.09M$751.83M$738.97M$737.10M$725.52M$524.26M$616.09M$586.10M$590.11M$476.60M$498.68M$581.74M$572.25M$433.27M$535.26M$505.04M$476.59M$300.25M$394.41M$360.95M$352.81M$247.58M$318.78M$308.59M
Surprise %--------------1.00%0.99%1.01%0.96%0.96%1.05%1.08%1.05%1.02%1.26%1.14%1.02%0.98%1.02%1.08%1.11%

Molina Healthcare's average Quarter SG&A projection for Sep 23 is $613.09M, based on 11 Wall Street analysts, with a range of $586.10M to $629.11M. The forecast indicates a -0.79% fall compared to MOH last annual SG&A of $618.00M (Jun 23).

Molina Healthcare EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts33454527844451159544755107599955
EPS--------------$5.37$5.53$0.97$4.00$4.29$4.45$1.78$2.47$3.19$3.93$0.57$3.14$4.68$3.02$2.71$2.81
Avg Forecast$6.94$7.34$7.98$7.66$6.22$6.46$6.85$6.60$5.77$5.81$5.56$5.68$4.34$4.88$5.10$5.19$4.02$4.22$4.33$4.66$2.75$2.80$3.39$3.67$0.96$2.20$4.91$2.97$2.65$2.72
High Forecast$7.91$8.36$9.08$8.73$7.08$7.36$7.81$6.77$5.89$5.93$5.59$5.68$4.50$5.06$5.81$5.91$4.57$4.22$4.33$4.66$2.75$2.80$3.39$3.67$0.96$2.20$4.91$2.97$2.65$2.72
Low Forecast$6.52$6.89$7.49$7.19$5.84$6.06$6.43$6.41$5.39$5.68$5.54$5.68$4.27$4.67$4.78$4.87$3.77$4.22$4.33$4.66$2.75$2.80$3.39$3.67$0.96$2.20$4.91$2.97$2.65$2.72
Surprise %--------------1.05%1.06%0.24%0.95%0.99%0.96%0.65%0.88%0.94%1.07%0.60%1.43%0.95%1.02%1.02%1.03%

According to 11 Wall Street analysts, Molina Healthcare's projected average Quarter EPS for Sep 23 is $4.88, with a low estimate of $4.67 and a high estimate of $5.06. This represents a -9.12% decrease compared to MOH previous annual EPS of $5.37 (Jun 23).

Molina Healthcare Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
OSCROscar Health$13.50$28.00107.41%Buy
CVSCVS Health$44.04$73.5066.89%Buy
CICigna$265.59$400.0050.61%Buy
ELVElevance Health$366.30$542.1448.00%Buy
CNCCentene$57.81$81.5040.98%Buy
UNHUnitedHealth Group$485.52$618.7527.44%Buy
HUMHumana$233.89$292.1324.90%Hold
MOHMolina Healthcare$291.78$347.0018.93%Hold
ALHCAlignment Healthcare$10.83$10.00-7.66%Buy

MOH Forecast FAQ

Is Molina Healthcare a good buy?

No, according to 8 Wall Street analysts, Molina Healthcare (MOH) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 37.50% of MOH's total ratings.

What is MOH's price target?

Molina Healthcare (MOH) average price target is $347 with a range of $297 to $400, implying a 17.73% from its last price of $294.73. The data is based on 8 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Molina Healthcare stock go up soon?

According to Wall Street analysts' prediction for MOH stock, the company can go up by 17.73% (from the last price of $294.73 to the average price target of $347), up by 35.72% based on the highest stock price target, and up by 0.77% based on the lowest stock price target.

Can Molina Healthcare stock reach $400?

MOH's average twelve months analyst stock price target of $347 does not support the claim that Molina Healthcare can reach $400 in the near future.

What are Molina Healthcare's analysts' financial forecasts?

Molina Healthcare's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $43.57B (high $48.04B, low $41.58B), average EBITDA is $2.28B (high $2.51B, low $2.17B), average net income is $1.51B (high $1.67B, low $1.43B), average SG&A $3.24B (high $3.58B, low $3.1B), and average EPS is $26.14 (high $29.02, low $24.75). MOH's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $47.28B (high $52.34B, low $45.05B), average EBITDA is $2.47B (high $2.74B, low $2.35B), average net income is $1.73B (high $1.97B, low $1.62B), average SG&A $3.52B (high $3.9B, low $3.35B), and average EPS is $29.92 (high $34.07, low $28.08).

Did the MOH's actual financial results beat the analysts' financial forecasts?

Based on Molina Healthcare's last annual report (Dec 2022), the company's revenue was $31.97B, beating the average analysts forecast of $30.89B by 3.49%. Apple's EBITDA was $1.56B, beating the average prediction of $1.44B by 8.21%. The company's net income was $792M, missing the average estimation of $853.1M by -7.16%. Apple's SG&A was $2.31B, missing the average forecast of $2.32B by -0.34%. Lastly, the company's EPS was $13.7, missing the average prediction of $17.22 by -20.46%. In terms of the last quarterly report (Jun 2023), Molina Healthcare's revenue was $8.33B, beating the average analysts' forecast of $8.32B by 0.07%. The company's EBITDA was $485M, beating the average prediction of $435.02M by 11.49%. Molina Healthcare's net income was $309M, beating the average estimation of $294.19M by 5.03%. The company's SG&A was $618M, missing the average forecast of $619.44M by -0.23%. Lastly, the company's EPS was $5.37, beating the average prediction of $5.1 by 5.32%